Polysulfated Glycosaminoglycan (PSGAG) (Adequan Injection)
Canine Adequan is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of caninesynovial joints
In the clinical efficacy trial, 24 dogs were treated with Adequan® Canine
twice weekly for 4 weeks. Possible adverse reactions were reported after 2.1% of the injections.These included transient pain at the injection site (1 incident), transient diarrhea (1 incident each in 2 dogs), and abnormal bleeding (1 incident). These effects were mild and self-limiting and did not require interruption of therapy.